Graypoint LLC Abb Vie Inc. Transaction History

Graypoint LLC

$1.52 Billion
Q3 2024

A detailed history of Graypoint LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Graypoint LLC holds 17,520 shares of ABBV stock, worth $3.15 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

17,520

Previous 15,800 10.89%

Holding current value

$3.15 Million

Previous $2.71 Million 27.64%

% of portfolio

0.23%

Previous 0.19%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$163.84 - $199.33 $281,804 - $342,847	1,720 Added 10.89%	17,520 $3.46 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $169,340 - $197,751	1,094 Added 7.44%	15,800 $2.71 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $268,497 - $305,928	1,680 Added 12.9%	14,706 $2.68 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $293,776 - $330,860	-2,135 Reduced 14.08%	13,026 $2.02 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $599,418 - $693,914	4,487 Added 42.04%	15,161 $2.26 Million
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $220,894 - $274,888	-1,667 Reduced 13.51%	10,674 $1.44 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $413,439 - $476,137	2,859 Added 30.15%	12,341 $1.97 Million
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $167,908 - $201,366	-1,214 Reduced 11.35%	9,482 $1.53 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $206,817 - $237,206	1,541 Added 16.83%	10,696 $1.44 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $115,463 - $146,791	-839 Reduced 8.4%	9,155 $1.4 Million
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $461,798 - $572,961	3,499 Added 53.87%	9,994 $1.62 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $133,320 - $168,689	1,241 Added 23.62%	6,495 $879,000
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $74,905 - $85,029	-704 Reduced 11.82%	5,254 $567,000
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $86,903 - $96,815	826 Added 16.1%	5,958 $671,000
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $67,108 - $73,878	656 Added 14.66%	5,132 $555,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $57,147 - $77,155	710 Added 18.85%	4,476 $480,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $30,412 - $35,693	354 Added 10.38%	3,766 $330,000
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $23,918 - $32,006	326 Added 10.56%	3,412 $334,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $199,047 - $301,779	3,086 New	3,086 $235,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account